ACTIVE

DR I. GOFITA REUMATOLOOG

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result143,3 k €+8,4 %over 1 year
Gross margin174,7 k €+4,6 %over 1 year
Equity437,1 k €+48,8 %over 1 year

Identity

Source · BCE/KBO

DR I. GOFITA REUMATOLOOG is a Private limited company incorporated in 2022. Its registered office is in Genk.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0791.263.345
Incorporation
22/09/2022
Legal form
Private limited company
Registered office
Weg naar As 40 box 12
3600 Genk · FlandreSee on map
Contributed capital
3 000,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 4 filings

Trend over 4 financial years

2025202420232022
Income statement
Gross margin174,7 k €167 k €157,6 k €50 k €
EBITDA173,9 k €165,4 k €155,8 k €49,5 k €
Operating result167,8 k €160 k €151,4 k €49,2 k €
Net result143,3 k €132,2 k €119,6 k €39 k €
Balance sheet
Equity437,1 k €293,8 k €161,6 k €42 k €
Total assets480,6 k €347,5 k €205,9 k €62,1 k €
Cash8,6 k €43,7 k €40,3 k €12,1 k €
Debts43,5 k €53,7 k €44,3 k €20,1 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

Ioana Gofita

Director · since 22 septembre 2022

Active

Ended mandates

Ioana Gofita

Director

Ended

Other companies at this address

Weg naar As 40 3600 Genk
CompanyCBE no.
DR. H. GOETHUYS● Active
0887.539.508
Judenti● Active
1041.437.926
Vereniging van mede-eigenaars Residentie Kestemont te Genk, Weg naar As 40● Active
0680.536.558

Full financial information

Source · NBB
2025202420232022
Type of accountMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202322/09/2022
Closing of the financial year31/12/202531/12/202431/12/202331/12/2022
Length of the financial year12 months12 months12 months4 months
Filing date30/07/202614/08/202527/08/202403/07/2023
General meeting26/06/202627/06/202528/06/202430/06/2023
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202526/06/202630/07/2026DutchPDF
Micro model31/12/202427/06/202514/08/2025DutchPDF
Micro model31/12/202328/06/202427/08/2024DutchPDF
Micro model31/12/202230/06/202303/07/2023DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

Ioana Gofita

Director · since 22 septembre 2022

Active

Ended mandates

Ioana Gofita

Director

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office24/10/2023
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other25/11/2022
    DIVERSEN
    PDF
  • Other26/09/2022
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025143,3 k €↑
  2. 2024
    Annual accounts 2024132,2 k €↑
  3. 2023
    Annual accounts 2023119,6 k €↑
  4. 2022
    Annual accounts 202239 k €
  5. 22/09/2022
    IncorporationPrivate limited company